BIVI - BioVie Announces Topline Results from Phase 2 ADDRESS—LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.